Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1186, 2008-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
US FDA issues early communication about Xigris safety
Reactions Weekly, Vol. 1, Iss. 1239, 2009-01 ,pp. :
Ortho Biotech concerned by FDA decision on ESAs
Reactions Weekly, Vol. 1, Iss. 1194-1195, 2008-01 ,pp. :
Combined Thiazolidinedione-Insulin Therapy: Should We Be Concerned About Safety?
Drug Safety, Vol. 27, Iss. 12, 2004-01 ,pp. :
FDA is reviewing safety of omalizumab
Reactions Weekly, Vol. 1, Iss. 1262, 2009-01 ,pp. :